tetano
Editor, Senior Moderator
Neurol Clin Neurosci
. 2021 Mar;9(2):159-165.
doi: 10.1111/ncn3.12482. Epub 2021 Feb 1.
Infection control in the respiratory care of coronavirus disease-19 patients with neuromuscular diseases
Tsuyoshi Matsumura[SUP] 1 [/SUP], Toshio Saito[SUP] 1 2 [/SUP], Masahide Mori[SUP] 2 3 [/SUP], Miki Kishida[SUP] 2 4 [/SUP], Kengo Tamagaki[SUP] 5 [/SUP], Yoshiaki Yoshida[SUP] 5 [/SUP], Yuka Ishikawa[SUP] 6 [/SUP], Kiyonobu Komai[SUP] 7 [/SUP], Kazuya Goto[SUP] 8 [/SUP], Tetsuo Komori[SUP] 9 [/SUP]
Affiliations
Abstract
Close contact is unavoidable in the care of patients with neuromuscular diseases (NMD). In addition, respiratory physiotherapy and noninvasive ventilation generate massive amounts of aerosols. Caring for a patient suffering from coronavirus disease-19 raises concerns about the risk of infection not only to the caregiver and/or medical staff but also to other individuals in contact with these personnel. We reviewed the points to be noted in infection control when a patient with neuromuscular diseases receiving respiratory care is infected with COVID-19 and summarizes the recommendation. Infected patients must be isolated in a negative-pressure or actively ventilated room. Clear zoning separating clean and infected areas should be performed for pathogen containment. Caregivers should wear appropriate personal protective equipment and thoroughly clean their hands. Leak-prevention measures and the use of proper respiratory circuits and filters with virus-removal performance are crucial to reducing aerosols in noninvasive ventilation. Although respiratory physiotherapy is essential, treatment should be minimized in consideration of the infection state and sputum status, and alternative therapies such as postural drainage should be carefully considered. Infection control is distinctly obligate; however, it impairs the quality of life and activity of daily living significantly. We should implement it with enough ethical consideration, adequate explanation, and patient consent. We hope that this paper will contribute to appropriate COVID-19 infection control in patients with neuromuscular diseases requiring respiratory care.
Keywords: Coronavirus infections (COVID?19); infection control; neuromuscular diseases; noninvasive ventilation; respiratory therapy.
. 2021 Mar;9(2):159-165.
doi: 10.1111/ncn3.12482. Epub 2021 Feb 1.
Infection control in the respiratory care of coronavirus disease-19 patients with neuromuscular diseases
Tsuyoshi Matsumura[SUP] 1 [/SUP], Toshio Saito[SUP] 1 2 [/SUP], Masahide Mori[SUP] 2 3 [/SUP], Miki Kishida[SUP] 2 4 [/SUP], Kengo Tamagaki[SUP] 5 [/SUP], Yoshiaki Yoshida[SUP] 5 [/SUP], Yuka Ishikawa[SUP] 6 [/SUP], Kiyonobu Komai[SUP] 7 [/SUP], Kazuya Goto[SUP] 8 [/SUP], Tetsuo Komori[SUP] 9 [/SUP]
Affiliations
- PMID: 33821184
- PMCID: PMC8013339
- DOI: 10.1111/ncn3.12482
Abstract
Close contact is unavoidable in the care of patients with neuromuscular diseases (NMD). In addition, respiratory physiotherapy and noninvasive ventilation generate massive amounts of aerosols. Caring for a patient suffering from coronavirus disease-19 raises concerns about the risk of infection not only to the caregiver and/or medical staff but also to other individuals in contact with these personnel. We reviewed the points to be noted in infection control when a patient with neuromuscular diseases receiving respiratory care is infected with COVID-19 and summarizes the recommendation. Infected patients must be isolated in a negative-pressure or actively ventilated room. Clear zoning separating clean and infected areas should be performed for pathogen containment. Caregivers should wear appropriate personal protective equipment and thoroughly clean their hands. Leak-prevention measures and the use of proper respiratory circuits and filters with virus-removal performance are crucial to reducing aerosols in noninvasive ventilation. Although respiratory physiotherapy is essential, treatment should be minimized in consideration of the infection state and sputum status, and alternative therapies such as postural drainage should be carefully considered. Infection control is distinctly obligate; however, it impairs the quality of life and activity of daily living significantly. We should implement it with enough ethical consideration, adequate explanation, and patient consent. We hope that this paper will contribute to appropriate COVID-19 infection control in patients with neuromuscular diseases requiring respiratory care.
Keywords: Coronavirus infections (COVID?19); infection control; neuromuscular diseases; noninvasive ventilation; respiratory therapy.